| Date Filed | Type | Description |
| 05/10/2023 |
4
| Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $1.2596, valued at
$25.2k
|
|
| 03/20/2023 |
4
| Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 6,999 shares
@ $1.783, valued at
$12.5k
|
|
| 03/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/15/2023 |
4
| Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 105,000 shares
@ $0
Granted 445,000 options to buy
@ $4.02, valued at
$1.8M
|
|
| 03/08/2023 |
4
| Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 5,441 shares
@ $5.056, valued at
$27.5k
|
|
| 03/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/20/2022 |
4
| Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 3,394 shares
@ $6.938, valued at
$23.5k
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2021 |
4
| Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 26,700 shares
@ $0 |
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
3
| Koenig Sheldon L. (COO) has filed a Form 3 on Esperion Therapeutics, Inc. |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Koenig Sheldon L. (EVP, Chief Commercial Officer) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 16,250 shares
@ $0
Granted 65,000 options to buy
@ $12.79, valued at
$831.4k
|
|
| 02/04/2019 |
4
| Koenig Sheldon L. (EVP, Chief Commercial Officer) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 125,000 options to buy
@ $27.1, valued at
$3.4M
|
|
| 02/04/2019 |
3
| Koenig Sheldon L. (EVP, Chief Commercial Officer) has filed a Form 3 on PORTOLA PHARMACEUTICALS INC |